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Abstract.  The relationship of N-linked glycosylation 
and association with heavy chain binding protein (BiP) 
to the secretion of Factor VIII (FVIIO, von Willebrand 
Factor (vWF), and tissue plasminogen activator (tPA) 
was studied in Chinese hamster ovary (CHO) cells. 
FVHI has a heavily glycosylated region containing 20 
clustered potential N-linked glycosylation sites. A 
significant proportion of FVIII was detected in a  stable 
complex with BiP and not secreted.  Deletion of the 
heavily glycosylated region resulted in reduced associ- 
ation with BiP and more efficient secretion. 
Tunicamycin treatment of cells producing this deleted 
form of FVIII resulted in stable association of un- 
glycosylated FVIII with BiP and inhibition of efficient 
secretion,  vWF contains  17 potential N-linked glyco- 
sylation sites scattered throughout the molecule,  vWF 
was transiently  associated with BiP and efficiently 
secreted demonstrating that CHO cells are competent 
to secrete a highly glycosylated protein,  tPA, which 
has three utilized N-linked glycosylation sites, ex- 
hibited low level association with BiP and was 
efficiently secreted.  Disruption of N-linked glycosyla- 
tion of tPA by either site-directed mutagenesis or 
tunicamycin treatment resulted in reduced levels of 
secretion and increased association with BiP.  This 
effect was enhanced by high levels of tPA expression. 
The glycosylation state and extent of association with 
BiP could be correlated with secretion efficiency. 
T 
HE information  that  determines the final destination 
of a  protein  is  contained  in  its  primary  structure. 
Structural  determinants  may dictate appropriate post- 
translational  modifications  necessary for correct conforma- 
tion. Many of the steps in the exocytic pathway of processing 
and transit of membrane-spanning  and secretory proteins in 
mammalian cells have been described (for reviews see Far- 
quhar,  1985; Kornfeld and Kornfeld,  1985). Previous work 
has shown that proteins destined for the exocytic pathway are 
first co-translationally  translocated  into the lumen of the en- 
doplasmic reticulum (ER) I. This step is mediated by a sig- 
nal sequence in most cases at or near the amino terminus  of 
the nascent chain  (Blobel and Dobberstein 1975; Walter et 
al., 1984). As the protein enters the ER the signal sequence 
is usually removed and a high mannose oligosaccharide  core 
unit is transferred  to asparagine  residues located in the se- 
quence Asn-X-Ser/Thr where Xcan be any amino acid except 
proline.  The efficiency of this N-linked  glycosylation  is de- 
pendent on the presentation  of an  appropriate  conforma- 
tion of the peptide chain as it enters the ER since potential 
N-linked glycosylation sites may no longer be accessible af- 
ter the protein has folded (Kornfeld  and Kornfeld,  1985). 
Proteins move from the ER to the Golgi apparatus  where 
modifications  such as sulfation,  O-linked glycosylation,  and 
1. Abbreviaaons  used in this paper: BiP, immunoglobulin  heavy chain bind- 
ing protein; ER,  endoplasmic reticulum; FVHI, factor VIII; tPA,  tissue 
plasminogen activator;  vWF, von Willebrand factor. 
processing of high mannose oligosaccharide  chains to com- 
plex types occur (Farquhar,  1985). Cleavage of propeptide 
sequences to the mature forms probably also occurs in Golgi 
and post-Golgi compartments (Orci et al., 1985). The move- 
ment of  proteins from the ER to the Golgi apparatus has been 
identified as the rate limiting  step in intracellular  transport 
(Lodish et al.,  1983; Fitting  and Kabat,  1982). Few of the 
proteins resident in the ER have been extensively studied for 
their interaction with secretory proteins transiting that cellu- 
lar compartment. 
A  native  component of the ER,  immunoglohulin  heavy 
chain  binding  protein  (BiP)  (Haas and Wable,  1983), has 
been shown to be involved in the posttranslational  processing 
of immunoglobulin  heavy chains (Bole et al., 1986). BiP has 
been found  associated with unassembled immunoglobulin 
heavy chains before their assembly with light chains.  Unas- 
sembled heavy chains remain associated with BiP and are not 
transported  to the Golgi apparatus  (Bole et al.,  1986). BiP 
can be released from its association  with heavy chains  in 
vitro by incubation  in the presence of ATP (Munro and Pel- 
ham,  1986). 
Recently, it has been shown that BiP is similar if not identi- 
cal to GRP78 (Munro and Pelham,  1986). GRP78 was ini- 
tially reported to be one of several proteins whose synthesis 
was induced by glucose starvation in chick fibroblasts  (Shiu 
et al.,  1977). Synthesis  of GRP78 can also be increased  by 
treatment  with inhibitors  of N-linked  glycosylation  such as 
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GRP78  has  been  shown  to  contain  a  carboxy-terminal 
tetrapeptide sequence that is involved in its retention in the 
ER (Munro and Pelham, 1987). BiP apparently binds glyco- 
proteins to a greater degree when normal N-linked glycosylo 
ation or folding is blocked (Bole et al., 1986; Gething et al., 
1986). These data together suggest that BiP/GRP78 may be 
actively involved in regulating the transport of membrane 
and secretory proteins from the ER to the Golgi apparatus. 
We have examined the role of  BiP/GRP78 in the processing 
and secretion of human factor VIII (FVIII), human tissue 
plasminogen activator  (tPA),  and human von Willebrand 
Factor (vWF) in stable Chinese hamster ovary (CHO) cell 
lines (Fig. 1). FVIII is synthesized as a single chain precur- 
sor of 250 kD and processed to a "heavy chain" of about 200 
kD and a "light chain" doublet of ,080 kD which are as- 
sociated by a metal ion bridge (Kaufman, R. J., L. C. Wasley, 
and A. J. Dorner, manuscript in preparation). FVffl has 25 
potential N-linked glycosylation sites.  20 of these sites are 
located within the middle one-third of the molecule defined 
as the B domain (Toole et al., 1984). Carbohydrate composi- 
tion analysis of FVIII secreted from CHO cells has shown 
that at least 75 % of the N-linked sites in the B domain are 
occupied (Steinbrink, D. R., personal communication). In 
frame deletion of most of this region to remove 18 potential 
N-linked glycosylation sites results in higher levels of FVIII 
secretion with no apparent change in the procoagulant activ- 
ity as assayed in vitro and in vivo (Toole et al., 1986) tPA 
has a molecular mass of 68 kD and contains four potential 
N-linked glycosylation sites,  of which three are used (Pohl 
et al.,  1984). vWF is a large glycoprotein synthesized as a 
300-kD precursor that contains 17 potential N-linked glyco- 
sylation sites and 235 cysteine residues involved in intra- and 
intermolecular disulfide bonding (Bonthron et al.,  1986). 
Pre-vWF forms dlmers in the endoplasmic reticulum and is 
subsequently proteolytically processed and modified by the 
addition of complex N-linked and O-linked carbohydrate 
groups in Golgi and postGolgi compartments to produce a 
220-kD mature form and 100-kD propeptide (Bonthron et 
al., 1986; Wagner and Marder, 1984). This group of  proteins 
was  selected  for  analysis  because  they  present  varying 
degrees of complexity of their intracellular processing and 
N-linked glycosylation patterns. In addition, unglycosylated 
forms could be derived by either tunicamycin treatment or 
deletion and site-directed mutagenesis. 
Our analysis of the secretion of FVIII, tPA, and vWF sug- 
gests that the efficiency of secretion can be inversely cor- 
related with the extent of BiP association. We propose that 
the utilization of N-linked glycosylation sites on a protein 
may influence the extent and stability of an association with 
BiP/GRP78 and this can be correlated with the efficiency of 
secretion. In the absence of normal N-linked glycosylation 
efficient secretion is impaired. The unglycosylated protein 
displays increased association with BiP and this complex is 
stable. We show that a block in efficient secretion is depen- 
dent in some cases on expression level. 
Materials and Methods 
Cell Culture and Cell Lines 
All CHO cell lines are derived from the dihydrofolate reductase  (DHFR) 
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Figure 1.  N-linked glycosylation pattern  of secretory proteins. 
Schematic representation shows the positions of potential N-linked 
giycosylation sites of the type Asn-X-SerlThr. Proteins are repre- 
sented as the single chain precursor form includins propeptides as 
deduced from published nucleotide sequences. Wavy line in LA 
represents region of  wild type FVIII deleted in LA. Arrows indicate 
sites of proteolytic processing that generate mature forms of the 
proteins, aa, amino acids. 
deficient cell line DUKX-BI1 (Urlaub and Chasin, 1980). Wild type tPA- 
producing CHO cell line, designated Clone 5, was obtained by cotransfor- 
mation with a DHFR gene and coamplification  as described (Kaufman et 
al.,  1985) and produces 10 mU/cell/d tPA activity,  vWF-producing  CHO 
cell line PM5F was obtained by DNA cotransformation  and coamplification 
of a vWF expression plasmid containing an adenosine deaminase marker 
gene as described (Bonthron et al.,  1986). PM5F was selected to 0.03 IxM 
deoxycoformycin and produces  1-2 ~tg/ml/d vWF antigen, tPA3x-producing 
cell lines were developed using vectors and procedures similar to those de- 
scribed for  Clone  5.  tPA3x-4  was  selected  for  resistance to  0.02  ttM 
methotrexate  and produces 0.006  mU/cell/d tPA  activity,  tPA3x-13 was 
selected  for resistance to 0.02 ~tM methotrexate  and produces 1.23 mU/ 
cell/d tPA activity. FVIH-producing CHO cell line (clone 10AI)  was selected 
for resistance to 1 mM methotrexate and produces 1 U/mild FVIII activity. 
LA-producing CHO line (clone LA3-5) was selected for resistance to 1 taM 
methotrexate  and produces 1-2 U/mild. Assays for tPA, vWF, and FVIII 
have been described previously  (Bonthron et al.,  1986; Kaufman et al., 
1985; Toole et al.,  1984). 
Radiolabeling and Immunoprecipitation 
Approximately  2  ￿  106 cells per  10-cm dish were labeled in  1 ml of 
methionine-free medium containing  0.5  mCi [35S]methionine (New En- 
gland Nuclear,  Cambridge, MA) and 1% aprotinln (Sigma Chemical Co., 
St. Louis, MO). Chase was done in the cell line's normal growth medium 
containing excess unlabeled methionine  and aprotinin. Tunicamycin (Sigma 
Chemical Co.), used at a concentration of 10 ttg/ml in the cell line's normal 
growth  medium,  was  added  1 h  before pulse labeling and maintained 
throughout the pulse/chase.  Cell lysates were prepared in 1x  lysis buffer 
(0.15 M NaCI, 0.05 M Tris-HCl, pH 7.5, 0.05% SDS,  1% NP-40) on ice. 
Equivalent volumes of cell extract or conditioned medium were immuno- 
precipitated at 4~  with either rabbit anti-vWF antibody (Behring Diagnos- 
tics, American Hoechst Corp., San Diego, CA), anti-BiP monoclonal anti- 
body culture supernatant (Bole et al.,  1986), anti-tPA monoclonal ascites 
fluid  (provided  by G.  Larsen,  Genetics Institute),  monoclonal antibody 
specific for the 80-kD light chain of FVIH (Hybridtech Inc., San Diego, 
CA), or monoclonal antibody specific for the heavy chain of FVIH (pro- 
vided by W. Foster, Genetics Institute). Rabbit anti-mouse IgG (CooperBio- 
medical,  Malvern,  PA)  or  staphylococcal  protein  A  immobilized  on 
Sepharose  beads was used as the precipitating  agent.  Precipitated  protein 
was analyzed on 5-12 % polyacrylamide  gradient gels, or 5 or 6 % polyacryl- 
amide gels using the Laemmli buffer system (Laemmli, 1970), followed by 
treatment with EN3HANCE  (New  England Nuclear), and drying.  Band 
intensity on autoradiugrams  was quantitated  using an ultroscan laser den- 
sitometer (Model No. 2202; LKB Instruments, Gaithersburg, MD). 
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Association of  Factor VIII with BiP 
The association of FVIII with BiP was measured by compar- 
ing the amount of FVIII detected by immunoprecipitation of 
cell lysates using  a  monoclonal antibody specific for BiP 
versus that detected by immunoprecipitation using a mono- 
clonal antibody specific for FVIII. A stable FVHI-producing 
CHO  cell line was  labeled  for  1 h  with  [35S]methionine, 
lysed, and immunoprecipitated as described in Materials and 
Methods. PAGE revealed a major band migrating with a mo- 
lecular mass of  250 kD, immunoprecipitated with anti-FVIII 
antibody that represents the single chain precursor FVIII 
(Fig.  2,  lane 1).  Immunoprecipitation with anti-BiP anti- 
body revealed BiP with a molecular mass of  78 kD and a 250- 
kD band migrating with the same mobility as single chain 
FVIII (Fig. 2, lane 2). As measured by densitometry, *85 % 
of the FVIII was detected in a complex with BiP. Only the 
250-kD single chain form was found associated with BiP. No 
processed 80-kD form was coprecipitated by the anti-BiP 
Figure 2.  Association of wild  type FVHI with  BiP. Wild type 
FVIII-producing CHO cells were pulse labeled for 1 h with [~sS]- 
methionine followed by a 4- and 20-h chase with medium contain- 
ing excess unlabeled methionine. Cell extracts (CE) and condi- 
tioned medium (CM) were prepared and immunopreeipitated with 
anti-FVIII  light  chain-specific  monoclonal  antibody  (VIII) or 
anti-BiP monoclonal antibody (BiP). The FVIII antibody recog- 
nizes the 80-kD light chain doublet and 250-kD single chain forms. 
An autoradiogram of a 6% polyacrylamide get is shown. Solid cir- 
cles indicate positions of single chain and light chain FVIII and the 
asterisk indicates position of BiP. 
antibody although the 80-kD doublet can be detected in the 
cells  by  immunoprecipitation  using  anti-FVIII  antibody. 
The other bands present in the inununoprecipitations most 
probably represent degradation products of FVIII, which is 
very sensitive to proteolytic activity. 
After a 4-h chase mature heavy chain, migrating as a broad 
smear around 200  kD,  and  a  80-kD doublet representing 
light chain were detected by immunoprecipitation of  the con- 
ditioned medium with anti-FVIII antibody (Fig. 2, lane 5). 
It is difficult to visualize and quantitate the 200-kD species 
in the medium because of its heterogeneity and since the 
precipitating antibody is specific for the light chain, only 
heavy chain associated with light chain will be detected. Im- 
munoprecipitation of conditioned medium with anti-BiP an- 
tibody detected a slight amount of  BiP that was not associated 
with mature FVIII (Fig. 2, lane 6). The amount ofintracellu- 
lar FVIII associated with BiP decreased to <50% of the total 
intracellular amount after a 4-h chase (Fig. 2, compare lanes 
3 and 4).  After a 20-h chase the intracellular single chain 
FVIII has begun to degrade as indicated by the smearing of 
the 250 kD band. Most of the FVIII was coprecipitated using 
anti-BiP antibody, indicating that most of the remaining in- 
tracellular FVIII was associated with BiP (Fig. 2, compare 
lanes 7and 8). Little intraceUular 80-kD light chain was de- 
tected by immunoprecipitation with anti-FVIII antibody in- 
dicating that none remains in the cell (Fig. 2, lane 7). The 
absence of  the 80-kD doublet permits the detection of a band 
migrating with the mobility of BiP by anti-FVIII antibody 
immunoprecipitation (Fig. 2, lane 7). The band of roughly 
200 kD is an artifact since it is also present in the LA and 
vWF  immunoprecipitations  described  below  and  is  most 
likely an endogenous CHO protein. With time the amount 
of BiP had increased in the conditioned medium but an as- 
sociation with secreted FVIII was not detected (Fig. 2, lanes 
9 and 10).  A  small amount of BiP is either released from 
damaged cells or secreted at a low rate. 
The association of BiP with the deleted form of FVIII 
called LA was examined in a similar manner. LA has only 
seven potential N-linked sites compared with 25 on wild type 
FVIII and is processed and efficiently secreted in a biologi- 
caliy active form by CHO cells (Toole et al.,  1986).  After 
a  1-h pulse with [35S]methionine  ~60% of intracellular sin- 
gle chain LA was associated with BiP based on densitometry 
(Fig. 3, compare lanes 1 and 2). Single chain LA migrates 
as a doublet with a molecular mass of 150 kD and the light 
chain migrates as a doublet with a molecular mass of 80 kD. 
As observed with FVIII the single chain form but not the 
80-kD light chain was detected in a complex with BiP by 
coprecipitation using anti-BiP antibody. 
After a 4-h chase the association of LA with BiP was de- 
creased significantly compared to the earlier time point ffig. 
3, compare lanes 3 and 4). Approximately 10% of the intra- 
cellular single chain LA was associated with BiP based on 
densitometry. In the conditioned medium, single chain form 
of 150 kD, processed heavy chain form migrating as a diffuse 
band around 90 kD, and 80-kD light chain doublet were de- 
tected  by  immunoprecipitation  with  anti-FVIII  antibody 
(Fig.  3, lane 5). These are the expected secreted forms of 
LA.  Immunoprecipitation with anti-BiP antibody detected 
some  BiP  in  the  conditioned medium but  it was  not as- 
sociated with LA (Fig. 3, lane 6). After a 20-h chase only 
a small amount of  LA remained in the cell and the proportion 
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were pulse  labeled for 1 h  with  [3SS]methionine  followed by a 
4- and 20-h chase with medium containing excess  unlabeled methio- 
nine. Cell extracts (CE) and conditioned medium (CM) were pre- 
pared and immunoprocipitateA  with anti-FVIH light chain-specific 
monoclonal  antibody  (VIII)  or  anti-BiP  monoclonal  antibody 
(BiP). An autorndiogram of a 6% polyacrylamide gel is shown. 
Solid circles indicate positions of single chain and light chain LA 
and the asterisk indicates position of BiP. 
of this LA which was associated with BiP was slight (Fig. 
3, compare lanes 8 and  7). 
Immunoprecipitation with a control antibody precipitated 
little wild type FVIII or LA indicating that the association 
detected with BiP was not the result of nonspecific precipita- 
tion (data not shown). After precipitation with anti-BiP anti- 
body, complexes of BiP with FVIII or LA were dissociated 
to a slight degree by incubation in the presence of 1 mM ATP 
(data not shown). The dissociated protein can be recovered 
by immunoprecipitation with anti-FVIII antibody. This re- 
sult proves that the protein associated with BiP is FVIII since 
the released material was recognized by FVIII-specific anti- 
bodies. 
These experiments demonstrate that LA exhibits a  tran- 
sient association with BiP in contrast to wild type FVIII. LA 
is not retained intracellularly for as long a time in a complex 
with BiP as wild type FVIII.  Deletion of the highly gly- 
cosylated region to produce LA results in a protein which is 
associated with BiP to a lesser degree than wild type FVIII. 
This suggests that the complexity of N-linked glycosylation 
of FVIII may influence the degree of BiP association. 
Effect of Tunicamycin on the Association 
of  LA with BiP 
It has been previously reported with influenza hemagglutinin 
(Gething  et  al.,  1986)  and  immunoglobulin  heavy chain 
Figure 4. Association of LA with BiP in tunicamycin-treated (+) 
or untreated (-) cells. LA-producing CHO cells were pretreated for 
1 h with 10 I~g/ml tunicamycin and pulse labeled for 30 min with 
[35S]methionine followed by a 4-h chase as described in the text. 
Cell extracts (CE) and conditioned medium (CM) were prepared 
and  immunoprecipitated  with  anti-FVIII  heavy  chain  specific 
monoclonal  antibody  (VIII)  or  anti-BiP  monoclonal  antibody 
(BiP). Lanes 1-5, untreated cells; lanes 6-10, tunicamycin-treated 
cells.  An autoradiogram of a 6% polyacrylamide gel is shown. 
Solid circles indicate positions of single chain and light chain LA 
and the asterisk indicates position of BiP. 
(Bole et al., 1986) that disruption of the N-linked glycosyla- 
tion results in greater association with BiE To examine this 
effect with LA, CHO cells producing LA were treated with 
tunicamycin,  which  prevents  N-linked  glycosylation  by 
blocking the formation of the lipid-linked oligosaccharide 
donor (Takatsuki et al.,  1975). After a  30-rain pulse with 
[3~S]methionine  and  4-h  chase,  extracts  of untreated  or 
tunicamycin-treated cells were prepared and immunoprecip- 
itated with anti-FVHI antibody or anti-BiP antibody. In un- 
treated cells most of the  150-kD  single chain LA was as- 
sociated with BiP after the 30-min pulse (Fig, 4, compare 
lanes 1 and 2). This association decreased after a 4-h chase 
(Fig. 4, compare lanes 3 and 4). At this time the secreted 
forms with molecular mass of 150, 90, and 80 kD were de- 
tected by immunoprecipitation of the conditioned medium 
with anti-FVIII antibody (Fig. 4, lane 5). In the presence 
of tunicamycin the molecular mass of single chain LA was 
reduced consistent with the absence of N-linked glycosyla- 
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ing CHO ceils were pulse labeled for 1 h with [3~S]- 
methionine followed  by a 4- and 20-h chase with unla- 
beled medium.  Cell extracts (CE) and conditioned 
medium (CM) were prepared  and  immunoprecipi- 
tated  with  anti-vWF  antibody  (vWF) or  anti-BiP 
monoclonal antibody (BiP) as described in the text. 
An  autoradiogram of a  5%  polyacrylamide gel  is 
shown. Solid circles indicate positions of precursor 
and processed forms ofvWF and the asterisk indicates 
position of BiP. 
tion, and all of this unglycosylated protein was associated 
with BiP after a 30-min pulse labeling (Fig. 4, compare lanes 
6 and 7). The proportion of intracellular LA associated with 
BiP was unchanged after a 4 h chase (Fig. 4, lanes 8 and 9) 
and little secretion of LA was detected (Fig.  4,  lane 10). 
These  observations  indicate  that  disruption  of  N-linked 
glycosylation  reduced efficient secretion of  LA and increased 
its association with BiP compared with the normally gly- 
cosylated molecule. Thus, molecules that were not compe- 
tent for secretion in the absence of N-linked glycosylation 
were found in a complex with BiP. By analogy, the incom- 
plete occupancy of the multiple potential glycosylation sites 
on wild type FVIII might influence the extent and stability 
of its association with BiP. 
Association of vWF with BiP 
It was possible that CHO cells are deficient in some aspect 
of the secretory pathway and therefore cannot properly pro- 
cess a complex glycoprotein. To rule out this possibility, we 
examined the processing of vWF.  The precursor form of 
vWF has 17 N-linked glycosylation sites distributed along the 
molecule. After a 1-h pulse labeling a major band migrating 
with a molecular mass of 260 kD was immunoprecipitated 
from a cell lysate by anti-vWF antibody (Fig. 5, lane 2). This 
band  represents the precursor form of vWE  Immunopre- 
cipitation  with  anti-BiP  antibody detected a  78-kD  band 
representing BiP and a band that comigrates with the vWF 
precursor (Fig. 5, lane 1). Less than 10% of the intracellular 
vWF was associated with BiP. vWF was efficiently secreted 
such that after a 4-h chase little of  the 260-kD precursor form 
remained in the cell (Fig. 5, lane 4). Immunoprecipitation 
of conditioned medium  with  anti-vWF antibody revealed 
processed forms of vWF with molecular mass  of 275 and 
220 kD  (Fig.  5,  lane 6),  while immunoprecipitation with 
anti-BiP antibody did not precipitate any vWF (Fig. 5, lanes 
5  and  7).  Little if any of these processed forms were ob- 
served intracellularly, which is consistent with previous ob- 
servations (Bonthron et al.,  1986; Wasley, L. C., and R. J. 
Kaufman, unpublished data). After a 4-h chase only 4% of 
intracellular vWF was associated with BiP (Fig. 5, compare 
lanes 3 and 4). Little if any vWF-BiP complex was observed 
after a 20-h chase (Fig. 5, compare lanes 7and 8). Immuno- 
precipitation with a control antibody precipitated little vWF, 
ruling out nonspecific precipitation (data not shown). Thus, 
vWF, a large complex glycoprotein, displays a low level of 
association with BiP and is efficiently secreted from CHO 
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cates that CHO cells are competent to efficiently  process and 
secrete a highly glycosylated glycoprotein. 
Association of tPA with BiP 
To further analyze the role of glycosylation on protein secre- 
tion and  BiP association,  we examined the processing of 
glycosylated and unglycosylated forms of tPA in CHO cells. 
tPA has four potential N-linked glycosylation sites, of which 
three are used (Pohl et al.,  1984).  PAGE resolves tPA as a 
doublet of roughly 68 kD due to variability in the utilization 
of one of the glycosylation sites,  tPA3x is a genetically en- 
gineered mutant in which the three normally used N-linked 
glycosylation sites  have  been  abolished  by  asparagine  to 
glutamine codon changes in the canonical recognition site 
sequence (Larsen, G. R., M. Metzger, P. Horgan, Y. Blue, 
and K. Henson, manuscript in preparation). 
Glycosylated  wild type tPA (tPAwt) is efficiently  processed 
and secreted at high levels by a  CHO cell line designated 
Clone 5 (Kaufman et al.,  1985).  After a 30-min pulse with 
[35S]methionine  tPAwt  exhibited  a  slight  association  with 
BiP. Less than 5 % of the intracellular tPA that was precipi- 
tated using  anti-tPA antibody (Fig.  6  A,  lane 1)  was co- 
precipitated using anti-BiP antibody (Fig. 6 A, lane 2). After 
a 1- or 3-h chase some tPAwt remained in the cell as detected 
by immunoprecipitation with anti-tPA antibody (Fig.  6 A, 
lanes 3 and 5). No tPA was coprecipitated using anti-BiP an- 
tibody (Fig. 6 A, lanes 4 and 6). Thus, at high expression 
levels tPAwt is correctly processed and secreted with low de- 
tectable association with BiP.  Immunoprecipitation of cell 
extracts with a control antibody precipitated little tPA com- 
pared with that immunoprecipitated with anti-BiP antibody 
(data not shown).  Therefore, the small amount of tPA as- 
sociated with BiP is not due to nonspecific coprecipitation. 
When Clone 5 cells were subjected to a pulse labeling of only 
2  min the amount of intracellular tPA associated with BiP 
was •17%  compared with <5% after a 5-min pulse labeling 
(data not shown). This result suggests that a higher propor- 
tion of tPA is associated with BiP at an early stage after syn- 
thesis compared with longer pulse-labeling periods. 
The processing of tPA3x in a cell line called tPA3x-4 was 
examined to determine if the absence of N-linked glycosyla- 
tion would prevent the efficient secretion of tPA.  This un- 
glycosylated form oftPA displayed little association with BiP 
(Fig. 6 B, compare lanes 2 and 3) and was efficiently secreted 
into the medium (Fig. 6 B, lanes 8 and 9). The time course 
of its transit through the cell was similar to that observed for 
tPAwt. Less protein was detected in the cell after a 1- and 3-h 
chase (Fig. 6 B, lanes 4 and 6), indicating that tPA3x does 
not experience a block in its secretion due to the absence of 
N-linked glycosylation. Unglycosylated tPA is apparently in 
a secretion competent form which displays little association 
with BiP in this cell line. 
To  examine  if the  quantitative  level of tPA  expression 
affected the degree of BiP association with tPA, cell lysates 
from cell lines producing different levels of tPA activity were 
compared by immunoprecipitation, tPA3x-13 produces 200- 
fold higher levels of tPA activity than tPA3x-4 as described 
in Materials and Methods. tPA3x-13 cells were labeled for 30 
min  with  [35S]methionine  followed by  1-  and  3-h  chases. 
Cell  lysates  were prepared  and  immunoprecipitated with 
Figure 6. Association oftPA with BiP. (A) Wild type tPA-producing 
CHO cells were pulse labeled with [3SS]methionine  for 30 min fol- 
lowed by a 1- and 3-h chase with unlabeled medium. Cell extract 
(CE) and conditioned medium (CM) were prepared and immuno- 
precipitated with anti-tPA antibody (tPA)  or anti-BiP monoclonal 
antibody (B/P). A portion of  an autoradiogram of  a 5-12 % gradient 
polyacrylamide gel is shown. (B) tPA3x-producing CHO cells at 
low expression level were pulse labeled for 30 rain with [3SS]me- 
thionine followed  by a 1- and 3-h chase. Cell extract (CE) and con- 
ditioned medium  (CM) were prepared  and  immunoprecipitated 
with  anti-tPA  antibody (tPA) or anti-BiP  monoclonal antibody 
(BiP). A portion of a 5-12 % gradient polyacrylamide gel is shown. 
(C) tPA3x-producing  CHO cells at high expression level were pulse 
labeled for 15 min with [35S]methionine  followed by a 1- and 3-h 
chase. Cell extracts (CE) and conditioned medium (CM) were pre- 
pared  and  immunoprecipitated with  anti-tPA  antibody  (tPA) or 
anti-BiP  monoclonal antibody (B/P).  A portion of an autoradio- 
gram 10% polyacrylamide gel is shown. In all panels asterisks indi- 
cate position of BiP and solid circles indicate position of tPA. 
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antibody (Fig. 6 C, lanes 2, 4, and 7). In this case tPA3x ex- 
hibited an association with BiP (Fig. 6  C, compare lanes 1 
and 2) which was greater than that observed for either wild 
type tPA (Fig. 6 A) or the tPA3x-4 line (Fig. 6 B). Based on 
densitometry, ,,o14% of  the intracellular tPA3x in the high ex- 
pression line was associated with BiP after a 30-min pulse 
and a  1-h chase (Fig. 6  C, compare lanes 1-4).  Strikingly, 
after a 3-h chase •40%  of the tPA3x which remained in the 
cell was detected in a complex with BiP (Fig. 6 C, compare 
lanes 6 and 7). Immunoprecipitation with anti-tPA antibody 
of conditioned medium from these cells revealed secreted 
tPA3x (Fig. 6  C, lanes 5 and 8).  However, a population of 
the intracellular tPA was not competent for efficient  secretion 
and was detected in a stable complex with BiP. These obser- 
vations suggest that the efficiency of secretion and the extent 
of association with BiP of unglycosylated tPA is influenced 
by expression level. 
Effect of Tunicamycin on the Association 
of tPA with BiP 
Another way to examine unglycosylated forms of tPA is to 
inhibit N-linked glycosylation by tunicamycin treatment as 
described in  Materials and  Methods.  Immunoprecipitated 
unglycosylated tPA appears as a doublet (see Fig. 7, lanes 3 
and 8, for example). Since tPA is synthesized with an amino- 
terminal propeptide sequence (Pennica et al.,  1983)  most 
probably the higher molecular mass band represents the un- 
cleaved  pro-tPA  precursor  form  while  the  lower  band 
represents the mature form which has been processed to re- 
move  the  propeptide.  Only  the  pro-tPA  precursor  form 
should be present in the same compartment with BiP since 
propeptide cleavage probably occurs in Golgi or post-Golgi 
compartments (Orci et al., 1985) and BiP has been localized 
to the ER (Bole et al.,  1986; Dorner, A. J., and R. J. Kauf- 
man, unpublished data). Consistent with this interpretation 
is the observation that only the higher molecular mass form 
was found associated with BiP (Fig. 7, lanes 10 and//) while 
only the lower molecular mass form was detected in the con- 
ditioned medium (Fig. 7, lane 14). 
Tunicamycin treatment results in the accumulation of tPA 
in the ER as monitored by immunofluorescence using anti- 
tPA antibody (Wasley,  L.  C.,  and R.  J.  Kaufman, unpub- 
lished data).  Treatment of Clone 5  cells with tunicamycin 
resulted in increased association of unglycosylated tPA with 
BiP compared with the glycosylated molecule. After a  15- 
rain pulse label the higher molecular mass form of tPA was 
coprecipitated with BiP (Fig. 7, compare lanes 3 and 4) to 
a greater degree than the glycosylated form (Fig. 7, compare 
lanes I  and 2). After a 1-h chase most of this precursor form 
that remains in the cell was detected in a complex with BiP 
(Fig. 7, compare lanes 5 and 6). Tunicamycin treatment of 
tPA3x-13 cells did not alter the amount of tPA3x associated 
with BiP compared with untreated cells. After a 15-min pulse 
label approximately equivalent percentages of tPA were as- 
sociated with BiP in the presence or absence of tunicamycin 
(Fig. 7, compare lanes 8-11).  After a 1-h chase ,,o14% of the 
intracellular tPA3x remained associated with BiP and this 
population represents most of the remaining precursor form 
(Fig. 7, lanes 12 and 13).  This profile of protein processing 
in tunicamycin-treated cells is similar to that observed for 
Figure Z Association of tPA with BiP in tunicamycin-treatcd (+) 
cells. Wild type tPA-producing cells (lanes 3-7) or tPA3x-produc- 
ing CHO cells at high expression level (lanes 10-14) were  pretreated 
for 1 h with 10 ~tg/mi mnicamycin and pulse labeled with [3SS]me- 
thionine for 15 rain followed by a l-h chase. Cell extracts (CE) and 
conditioned medium (CM) were prepared and immunoprecipitated 
with  anti-tPA  antibody  (tPA) or anti-BiP monoclonal antibody 
(BiP). Lanes I and 2 are cell extracts of a pulse label of untreated 
(-) wild type tPA producers. Lanes 8 and 9 are cell extracts of a 
pulse label of  untreated (-) tPA3x high level producers. An autora- 
diogram of a 10% polyacrylamide gel is shown. Solid circles indi- 
cates position of tPA and the asterisk indicates position of BiP. 
untreated tPA3x-13 cells (Fig. 6 C). There is an increase of 
intracellular mature form in tunicamycin-treated cells which 
may be due to a slower rate of  secretion. However, the overall 
similarity between treated and untreated tPA3x-13 cells indi- 
cates that the effect of tunicamycin on the secretion of wild 
type tPA is due to the absence of N-linked glycosylation on 
tPA rather than an indirect effect of the drug. 
It is striking that treatment of Clone 5 cells with tunicamy- 
cin (Fig. 7) produced a pattern of unglycosylated tPAwt pro- 
cessing that is similar to that observed for tPA3x at high ex- 
pression levels (Fig. 6 C). At lower expression levels, tPA3x 
showed little association with BiP (Fig. 6 B). We have also 
observed that in a cell line expressing lower levels of  tPA than 
that obtained in Clone 5 cells, the association of tPAwt with 
BiP was  less  affected by tunicamycin treatment  (data  not 
shown).  Thus,  as  the  result  of tunicamycin treatment  or 
mutagenesis, the degree of association of unglycosylated tPA 
with BiP is influenced by the expression level of tPA. 
Discussion 
The association of three secreted glycoproteins with BiP, a 
resident protein of the ER, was studied. The degree of as- 
sociation of a glycoprotein with BiP can be correlated with 
the efficiency of secretion and the occupancy of N-linked 
glycosylation sites. FVIII is a highly glycosylated glycopro- 
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clustered within the middle one-third of the protein. On the 
secreted form of FVIII a majority of these sites are occupied. 
We  have observed  a  high degree  of association between 
FVIII and BiP. Strikingly, we have detected a population of 
FVIII molecules which are apparently retained inside the 
cell in a stable complex with BiE This material may be com- 
posed  of secretion-incompetent molecules  which  remain 
associated with BiP in the ER. We have observed that se- 
cretion-competent FVIII appears in the conditioned medium 
6  h  after a  pulse  label,  after which little more FVIII is 
secreted (Wasley, L. C., and R.  J.  Kaufman, unpublished 
data). This further suggests that FVIII retained in a complex 
with BiP is not destined for secretion. Our study is the first 
description of the intracellular processing of FVIII and sug- 
gests a role for BiP in the secretion pathway of FVIII. 
In-frame deletion of most of the highly glycosylated inter- 
nal domain of FVIII produces a protein designated LA which 
retains procoagulant activity and displays higher levels  of 
secretion  compared  with  wild  type  FVIII  (Toole  et  al., 
1986). The degree of BiP association with LA, which has 
only seven potential N-linked sites,  was reduced compared 
with wild type FVIII. Furthermore, the association of LA 
with BiP was transient, while the association of wtFVIII with 
BiP was stable after a 20-h chase. Wild type FVIII that re- 
mained in the cell was not released from its association with 
BiP and apparently failed to exit the ER. Disruption of the 
N-linked  glycosylation of  LA  by  tunicamycin treatment 
promoted the association of LA with BiP and blocked its 
efficient secretion. We have also observed that inhibition of 
N-linked glycosylation  of wtFVIII by tunicamycin treatment 
blocked its secretion (data not shown). We conclude that the 
occupancy of the N-linked glycosylation sites on FVIII plays 
a role in its efficient secretion and in the extent and stability 
of its association with BiE 
Addition of the N-linked oligosaccharide core unit occurs 
as the protein translocates into the lumen of the endoplasmic 
reticulum during the process of protein folding (Kornfeld 
and Kornfeld, 1985). Once the protein has folded, potential 
glycosylation sites are no longer accessible (Kornfeld and 
Kornfeld, 1985). Consequently, the 20 N-linked sites clus- 
tered in the B domain of wtFVIII may be presented in an ap- 
propriate conformation for too short a  period of time for 
efficient glycosylation. Some molecules may, therefore, ex- 
hibit incomplete N-linked glycosylation. Since we have ob- 
served that inhibition of N-linked glycosylation enhances 
association with BiP; incomplete glycosylation  of FVIII may 
result in stable association with BiP and retention in the cell. 
Carbohydrate analysis has indicated that on secreted FVIII 
most of these sites are occupied suggesting that only heavily 
glycosylated FVIII is secreted. Deletion of the B domain in 
LA removed the peptide sequences containing the clustered 
glycosylation sites and resulted in transient association with 
BiP. This is consistent with a requirement for proper B do- 
main processing in efficient FVIII secretion. Thus, BiP may 
be involved in an early processing step for FVIII. An alterna- 
tive hypothesis is that due to the clustering of N-linked sites 
the B domain of FVIII presents an unusual conformation that 
BiP recognizes even if N-linked glycosylation is complete. 
Detailed analysis of BiP-associated FVIII should provide in- 
sight into which hypothesis is correct. 
vWF is efficiently  processed and secreted from CHO cells. 
We observed that vWF was only transiently associated with 
BiP. vWF has 235 cysteine residues involved in intra- and in- 
termolecular bonding suggesting that the complexity of the 
disulfide bonding does not influence association with BiP. 17 
potential N-linked glycosylation sites are spread throughout 
the molecule rather than clustered. These observations show 
that CHO cells are competent to efficiently secrete a highly 
glycosylated glycoprotein and further point to the unusual 
nature of the clustered sites on FVIII. 
Wild type tPA was also transiently associated with BiP. 
The proportion of the intracellular population detected in a 
complex with BiP was at least 10-fold less than that observed 
for FVIII. tPA is apparently processed and transits through 
the ER with little detectable interaction with BiP. The pro- 
portion of tPA associated with BiP was greater early after 
synthesis as detected after a very short pulse labeling. This 
result suggests that association of  tPA with BiP occurs during 
or immediately after its synthesis. The low level of tPA as- 
sociated with BiP may reflect the time of an initial processing 
event in the ER. However we cannot rule out that tPA as- 
sociated with BiP is not competent for secretion. Disruption 
of glycosylation by tunicamycin treatment resulted in  in- 
creased association of the unglycosylated tPA with BiP and 
inhibition of efficient secretion. 
Of particular interest was the observation that tPA3x,  in 
which the three normally used glycosylation sites have been 
removed by asparagine  to  glutamine codon  changes,  ex- 
hibited only a slight association with BiP at low expression 
levels.  Since tPA3x  should be  structurally similar to un- 
glycosylated tPAwt synthesized in the presence of tunicamy- 
cin, it was unexpected that tPA3x was not associated with 
BiP. However, at expression levels of tPA3x approaching that 
obtained for tPAwt, we observed an association of  tPA3x with 
BiP that was highly reminiscent of that observed for un- 
glycosylated tPAwt synthesized in the presence of tunicamy- 
cin. This result indicates that differences in BiP association 
are  not due to  variation between cell lines  since  similar 
degrees of association were obtained for unglycosylated tPA 
obtained by either  tunicamycin treatment or  site-specific 
mutagenesis in different cell lines. 
We conclude that the retention of unglycosylated tPA in a 
complex with BiP is dependent on the expression level  of 
tPA. Consistent with this conclusion is our observation that 
in a cell line producing 25-fold less tPA activity than Clone 
5 the effect of tunicamycin treatment is less pronounced than 
in Clone 5. A possible explanation is that unglycosylated  tPA 
may aggregate when present at high concentration in the ER 
leading to a block in its secretion and consequent association 
with BiP. In this case BiP may both transiently interact with 
nascent tPA and bind aggregated protein. 
It has been reported that N-linked glycosylation can be 
crucial in the attainment of the native conformation of a pro- 
tein and that improper folding may result in protein aggrega- 
tion and decreased  solubility (Gibsen  et  al.,  1979, 1981; 
Leavitt et al., 1977). Each glycoprotein probably has a differ- 
ent oligosaccharide requirement for proper polypeptide fold- 
ing and solubility. A  previous study on influenza hemag- 
glutinin synthesis has shown that unfolded molecules are 
specifically associated with BiP and that disruption of N-linked 
glycosylation with tunicamycin results in increased associa- 
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cellular transport (Gething et al.,  1986).  Prevention of the 
glycosylation  of immunoglobulin heavy chain delays assem- 
bly with light chain and enhances BiP association perhaps 
by disrupting normal protein folding (Bole et al., 1986). Our 
results also suggest that the absence of  appropriate glycosyla- 
tion may cause retention of proteins in the ER in a complex 
with BiP. We postulate that this block in efficient secretion 
may be  due to  aggregation or  insolubility of improperly 
folded protein. In this case BiP may function to clear such 
aggregated protein from the cell (Pelham,  1986). 
Coprecipitation of intracellular secretory proteins  with 
BiP was predominantly observed when anti-BiP antibody 
was used as the precipitating antibody. Little radiolabeled 
BiP was observed to coprecipitate when antibody against the 
secretory protein was used. This observation suggests that 
under these labeling conditions a population of unlabeled 
BiP exists in the ER which can associate with nascent pro- 
teins as they translocate into the ER. Newly synthesized BiP 
has not entered this functional population and so little radio- 
labeled BiP is found in complexes. The formation of a com- 
plex may occur during or immediately after translocation. 
We conclude that the factors that determine the extent of BiP 
association and retention in the ER are active at an early 
stage of protein processing. 
Our results suggest that BiP/GRP78 plays an important 
role in the secretory pathway. BiP may be involved in an early 
step of the secretion pathway and so generally interacts with 
proteins as they move through the ER. The association of BiP 
with unglycosylated  proteins suggests that BiP may monitor 
the conformation of newly synthesized proteins in the ER. 
When an N-linked site is not appropriately occupied, an 
incorrectly folded protein may result and BiP remains as- 
sociated. Protein insolubility and aggregation could be in- 
fluenced by the appropriate utilization of N-linked glyco- 
sylation sites on a protein and by the concentration of the 
protein in the ER. However, we cannot completely rule out that 
the association of nonglycosylated  proteins with BiP reflects 
a common localization and aggregation of these proteins and 
BiP. When glycosylation and protein folding occur properly, 
the association with BiP is transient and the secretory path- 
way to the Golgi apparatus is traversed. If this association is 
transient and occurs early after synthesis, the detection of 
complexes that represent secretion-competent protein will 
require very short pulse-labeling periods. Our observation 
that a  significantly higher percentage of tPA is associated 
with BiP after a very short pulse labeling (17%) compared 
with longer time periods (<5 %) is consistent with this idea. 
However,  we  cannot rule  out the possibility that protein 
associated with BiP is not secretion competent and may be 
destined for degradation. Since approximately 30 min is re- 
quired for the secretion of tPA from CHO cells, the asso- 
ciation and dissociation of complexes with BiP must occur 
very soon after synthesis. This suggests that tPA remains in 
the ER for some time after release from the complex. This 
is consistent with the report that tfirneric forms of hemagglu- 
tinin are found in the ER after dissociation of  the monomeric 
forms from a complex with BiP (Gething et al.,  1986). 
Our experiments show that, in the case of FVIN, deletion 
of the heavily glycosylated region by removal of protein 
sequence resulted in reduced association with BiP.  When 
N-linked glycosylation was prevented by tunicamycin treat- 
merit or mutagenesis, association with BiP was increased and 
secretion decreased. This may be due to the inability of the 
unglycosylated protein to achieve native conformation or 
solubility necessary for transit through the ER. Under condi- 
tions  of appropriate  glycosylation, proteins  that are  effi- 
ciently secreted may only transiently associate with BiP. 
BiP/GRP78 may function to allow only correctly folded pro- 
tein to continue along the secretory pathway and to target 
aberrant protein for destruction. 
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